Compare ARMN & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARMN | CNTA |
|---|---|---|
| Founded | 1992 | 2020 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | N/A | 2021 |
| Metric | ARMN | CNTA |
|---|---|---|
| Price | $21.39 | $25.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $17.00 | ★ $38.00 |
| AVG Volume (30 Days) | 1.5M | ★ 1.6M |
| Earning Date | 03-11-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $770,175,000.00 | $15,000,000.00 |
| Revenue This Year | $84.90 | N/A |
| Revenue Next Year | $69.90 | N/A |
| P/E Ratio | $87.06 | ★ N/A |
| Revenue Growth | 58.96 | ★ 118.88 |
| 52 Week Low | $3.50 | $9.60 |
| 52 Week High | $21.33 | $30.58 |
| Indicator | ARMN | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 82.62 | 60.26 |
| Support Level | $19.82 | $21.50 |
| Resistance Level | $21.33 | $26.63 |
| Average True Range (ATR) | 0.84 | 1.13 |
| MACD | 0.24 | 0.52 |
| Stochastic Oscillator | 99.19 | 81.48 |
Aris Mining Corp is engaged in the acquisition, exploration, development, and operation of gold properties in Colombia, Guyana, and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, the Toroparu Project in Guyana, and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.